4.5 Article

USP7 is a SUMO deubiquitinase essential for DNA replication

Journal

NATURE STRUCTURAL & MOLECULAR BIOLOGY
Volume 23, Issue 4, Pages 270-277

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nsmb.3185

Keywords

-

Funding

  1. Spanish Ministry of Economy and Competitiveness (MINECO) [SAF2011-23753, SAF2014-57791-REDC]
  2. Worldwide Cancer Research [12-0229]
  3. Fundacio La Marato de TV3
  4. European Research Council [ERC-617840]
  5. Marie-Curie International Outgoing Fellowship from the Seventh Framework Programme for Research and Technological Development, Marie Curie Actions [235705]
  6. MINECO - European Regional Development Funds (FEDER) [BFU2014-55168-JIN]
  7. Danish Council for Independent Research
  8. Danish National Research Foundation
  9. MINECO [BES-2012-05 2030]
  10. Howard Hughes Medical Institute
  11. Banco Santander, through its Santander Universities Global Division
  12. Fundacion Botin
  13. The Danish Cancer Society [R90-A6031] Funding Source: researchfish
  14. Worldwide Cancer Research [12-0229] Funding Source: researchfish

Ask authors/readers for more resources

Post-translational modification of proteins by ubiquitin (Ub) and Ub-like modifiers regulates DNA replication. We have previously shown that chromatin around replisomes is rich in SUMO and poor in Ub, whereas mature chromatin exhibits an opposite pattern. How this SUMO-rich, Ub-poor environment is maintained at sites of DNA replication in mammalian cells remains unexplored. Here we identify USP7 as a replisome-enriched SUMO deubiquitinase that is essential for DNA replication. By acting on SUMO and SUMOylated proteins, USP7 counteracts their ubiquitination. Inhibition or genetic deletion of USP7 leads to the accumulation of Ub on SUMOylated proteins, which are displaced away from replisomes. Our findings provide a model explaining the differential accumulation of SUMO and Ub at replication forks and identify an essential role of USP7 in DNA replication that should be considered in the development of USP7 inhibitors as anticancer agents.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available